Guerbet SA

ENXTPA:GBT Stock Report

Market Cap: €315.2m

Guerbet Past Earnings Performance

Past criteria checks 2/6

Guerbet's earnings have been declining at an average annual rate of -31.2%, while the Medical Equipment industry saw earnings growing at 14.5% annually. Revenues have been growing at an average rate of 0.4% per year. Guerbet's return on equity is 8%, and it has net margins of 3.9%.

Key information

-31.2%

Earnings growth rate

-31.2%

EPS growth rate

Medical Equipment Industry Growth21.6%
Revenue growth rate0.4%
Return on equity8.0%
Net Margin3.9%
Next Earnings Update27 Mar 2025

Recent past performance updates

Recent updates

Guerbet SA (EPA:GBT) Might Not Be As Mispriced As It Looks After Plunging 29%

Nov 16
Guerbet SA (EPA:GBT) Might Not Be As Mispriced As It Looks After Plunging 29%

Is Guerbet (EPA:GBT) Using Too Much Debt?

Apr 27
Is Guerbet (EPA:GBT) Using Too Much Debt?

Further Upside For Guerbet SA (EPA:GBT) Shares Could Introduce Price Risks After 48% Bounce

Feb 29
Further Upside For Guerbet SA (EPA:GBT) Shares Could Introduce Price Risks After 48% Bounce

Returns On Capital At Guerbet (EPA:GBT) Paint A Concerning Picture

Feb 11
Returns On Capital At Guerbet (EPA:GBT) Paint A Concerning Picture

Guerbet SA (EPA:GBT) Screens Well But There Might Be A Catch

Jan 15
Guerbet SA (EPA:GBT) Screens Well But There Might Be A Catch

The Returns On Capital At Guerbet (EPA:GBT) Don't Inspire Confidence

Jul 22
The Returns On Capital At Guerbet (EPA:GBT) Don't Inspire Confidence

Guerbet SA's (EPA:GBT) Intrinsic Value Is Potentially 92% Above Its Share Price

Jul 27
Guerbet SA's (EPA:GBT) Intrinsic Value Is Potentially 92% Above Its Share Price

Analysts Have Been Trimming Their Guerbet SA (EPA:GBT) Price Target After Its Latest Report

Mar 28
Analysts Have Been Trimming Their Guerbet SA (EPA:GBT) Price Target After Its Latest Report

Is Guerbet (EPA:GBT) A Risky Investment?

Oct 25
Is Guerbet (EPA:GBT) A Risky Investment?

The Returns On Capital At Guerbet (EPA:GBT) Don't Inspire Confidence

Sep 23
The Returns On Capital At Guerbet (EPA:GBT) Don't Inspire Confidence

Is Now The Time To Look At Buying Guerbet SA (EPA:GBT)?

May 27
Is Now The Time To Look At Buying Guerbet SA (EPA:GBT)?

We Think Guerbet (EPA:GBT) Is Taking Some Risk With Its Debt

May 04
We Think Guerbet (EPA:GBT) Is Taking Some Risk With Its Debt

Is Guerbet SA (EPA:GBT) A Good Fit For Your Dividend Portfolio?

Apr 05
Is Guerbet SA (EPA:GBT) A Good Fit For Your Dividend Portfolio?

Guerbet SA's (EPA:GBT) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?

Mar 19
Guerbet SA's (EPA:GBT) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?

What Type Of Shareholders Make Up Guerbet SA's (EPA:GBT) Share Registry?

Mar 01
What Type Of Shareholders Make Up Guerbet SA's (EPA:GBT) Share Registry?

When Should You Buy Guerbet SA (EPA:GBT)?

Feb 10
When Should You Buy Guerbet SA (EPA:GBT)?

How Much Did Guerbet's(EPA:GBT) Shareholders Earn From Share Price Movements Over The Last Three Years?

Jan 28
How Much Did Guerbet's(EPA:GBT) Shareholders Earn From Share Price Movements Over The Last Three Years?

Guerbet SA (EPA:GBT) Shares Could Be 25% Above Their Intrinsic Value Estimate

Jan 13
Guerbet SA (EPA:GBT) Shares Could Be 25% Above Their Intrinsic Value Estimate

Would Guerbet SA (EPA:GBT) Be Valuable To Income Investors?

Dec 23
Would Guerbet SA (EPA:GBT) Be Valuable To Income Investors?

We Think Guerbet's (EPA:GBT) Statutory Profit Might Understate Its Earnings Potential

Dec 11
We Think Guerbet's (EPA:GBT) Statutory Profit Might Understate Its Earnings Potential

Do Its Financials Have Any Role To Play In Driving Guerbet SA's (EPA:GBT) Stock Up Recently?

Nov 27
Do Its Financials Have Any Role To Play In Driving Guerbet SA's (EPA:GBT) Stock Up Recently?

Revenue & Expenses Breakdown

How Guerbet makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

ENXTPA:GBT Revenue, expenses and earnings (EUR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 24841334940
31 Mar 24818284820
31 Dec 23796244710
30 Sep 23785-94700
30 Jun 23775-424690
31 Mar 23772-424590
31 Dec 22769-414500
30 Sep 22757-144390
30 Jun 22746134270
31 Mar 22741234180
31 Dec 21736334080
30 Sep 21724334050
30 Jun 21712334020
31 Mar 21715264110
31 Dec 20717184200
30 Sep 20751224290
30 Jun 20785264380
31 Mar 20802324520
31 Dec 19819374660
30 Sep 19813404680
30 Jun 19807434700
31 Mar 19801454630
31 Dec 18795474570
30 Sep 18793464560
30 Jun 18790464550
31 Mar 18800464530
31 Dec 17809464510
30 Sep 17807434480
30 Jun 17805404440
31 Mar 17791344380
31 Dec 16776294310
30 Sep 16709303980
30 Jun 16642313660
31 Mar 16566353190
31 Dec 15490392720
30 Sep 15462372560
30 Jun 15435352410
31 Mar 15422302350
31 Dec 14410262280
30 Sep 14405242260
30 Jun 14400232240
31 Mar 14395222230
31 Dec 13391202220

Quality Earnings: GBT has high quality earnings.

Growing Profit Margin: GBT became profitable in the past.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: GBT's earnings have declined by 31.2% per year over the past 5 years.

Accelerating Growth: GBT has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: GBT has become profitable in the last year, making it difficult to compare its past year earnings growth to the Medical Equipment industry (12.5%).

Return on Equity

High ROE: GBT's Return on Equity (8%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/17 09:37
End of Day Share Price 2024/12/17 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Guerbet SA is covered by 9 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Laurent GelebartBNP Paribas Exane
Arnaud CadartCIC Market Solutions (ESN)
Robin LeclercDegroof Petercam